Literature DB >> 24318197

Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles.

See Wei Tan1, Nashiru Billa.   

Abstract

We aimed to investigate the effects that natural lipids, theobroma oil (TO) and beeswax (BW), might have on the physical properties of formulated nanoparticles and also the degree of expulsion of encapsulated amphotericin B (AmB) from the nanoparticles during storage. Lecithin and sodium cholate were used as emulsifiers whilst oleic acid (OA) was used to study the influence of the state of orderliness/disorderliness within the matrices of the nanoparticles on the degree of AmB expulsion during storage. BW was found to effect larger z-average diameter compared with TO. Lecithin was found to augment the stability of the nanoparticles imparted by BW and TO during storage. An encapsulation efficiency (%EE) of 59% was recorded when TO was the sole lipid as against 42% from BW. In combination however, the %EE dropped to 39%. When used as sole lipid, TO or BW formed nanoparticles with comparatively higher enthalpies, 21.1 and 23.3 J/g respectively, which subsequently caused significantly higher degree of AmB expulsion, 81 and 83% respectively, whilst only 11.8% was expelled from a binary TO/BW mixture. A tertiary TO/BW/OA mixture registered the lowest enthalpy at 8.07 J/g and expelled 12.6% of AmB but encapsulated only 22% of AmB. In conclusion, nanoparticles made from equal concentrations of TO and BW produced the most desirable properties and worthy of further investigations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24318197      PMCID: PMC3969480          DOI: 10.1208/s12249-013-0056-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  The production and characteristics of solid lipid nanoparticles (SLNs).

Authors:  DongZhi Hou; ChangSheng Xie; KaiJin Huang; ChangHong Zhu
Journal:  Biomaterials       Date:  2003-05       Impact factor: 12.479

2.  Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.

Authors:  A A Attama; B C Schicke; T Paepenmüller; C C Müller-Goymann
Journal:  Eur J Pharm Biopharm       Date:  2006-12-16       Impact factor: 5.571

3.  A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil.

Authors:  A A Attama; C C Müller-Goymann
Journal:  Int J Pharm       Date:  2006-05-26       Impact factor: 5.875

4.  Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy.

Authors:  H Komatsu; A Kitajima; S Okada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-08       Impact factor: 1.645

5.  Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.

Authors:  V Jenning; A Gysler; M Schäfer-Korting; S H Gohla
Journal:  Eur J Pharm Biopharm       Date:  2000-05       Impact factor: 5.571

6.  Lipid-based vehicle for oral drug delivery.

Authors:  M Stuchlík; S Zák
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2001-12       Impact factor: 1.245

Review 7.  Amphotericin B.

Authors:  A Lemke; A F Kiderlen; O Kayser
Journal:  Appl Microbiol Biotechnol       Date:  2005-04-09       Impact factor: 4.813

8.  Comparison of wax and glyceride solid lipid nanoparticles (SLN).

Authors:  V Jenning; S Gohla
Journal:  Int J Pharm       Date:  2000-03-10       Impact factor: 5.875

9.  Formulation of amphotericin B as nanosuspension for oral administration.

Authors:  O Kayser; C Olbrich; V Yardley; A F Kiderlen; S L Croft
Journal:  Int J Pharm       Date:  2003-03-18       Impact factor: 5.875

10.  Characterization of diazepam submicron emulsion interface: role of oleic acid.

Authors:  M Y Levy; W Schutze; C Fuhrer; S Benita
Journal:  J Microencapsul       Date:  1994 Jan-Feb       Impact factor: 3.142

View more
  4 in total

1.  A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats.

Authors:  Hilda Amekyeh; Nashiru Billa; Kah-Hay Yuen; Sherlyn Lim Sheau Chin
Journal:  AAPS PharmSciTech       Date:  2015-01-15       Impact factor: 3.246

Review 2.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

3.  Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.

Authors:  Xiaolong Tang; He Zhu; Ledong Sun; Wei Hou; Shuyu Cai; Rongbo Zhang; Feng Liu
Journal:  Int J Nanomedicine       Date:  2014-11-24

4.  Properties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee'S Wax.

Authors:  Chloe See Wei Tan; Nashiru Billa; Clive J Roberts; David J Scurr
Journal:  Nanomaterials (Basel)       Date:  2014-12-19       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.